Sarcopenic obesity is associated with a faster decline in renal function in people with type 2 diabetes

To evaluate the association between sarcopenic obesity and the decline in estimated GFR in people with type 2 diabetes.

[1]  J. Batsis,et al.  Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies , 2018, Nature Reviews Endocrinology.

[2]  B. Davis,et al.  The Effects of eGFR Change on CVD, Renal, and Mortality Outcomes in a Hypertensive Cohort Treated With 3 Different Antihypertensive Medications , 2018, American journal of hypertension.

[3]  T. Yoshimoto,et al.  Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: a retrospective observational study , 2018, Cardiovascular Diabetology.

[4]  R. Nelson,et al.  The Global Epidemiology of Diabetes and Kidney Disease. , 2018, Advances in chronic kidney disease.

[5]  K. Patel,et al.  Comparison between Different Measures of Body Fat with Kidney Function Decline and Incident CKD. , 2017, Clinical journal of the American Society of Nephrology : CJASN.

[6]  T. Yoshimoto,et al.  Sarcopenia is associated with incident albuminuria in patients with type 2 diabetes: A retrospective observational study , 2017, Journal of diabetes investigation.

[7]  T. Davis,et al.  The relationship between estimated glomerular filtration rate trajectory and all-cause mortality in type 2 diabetes: the Fremantle Diabetes Study. , 2016, European journal of endocrinology.

[8]  Qifu Li,et al.  Abdominal Obesity Is More Closely Associated With Diabetic Kidney Disease Than General Obesity , 2016, Diabetes Care.

[9]  M. Woodward,et al.  Past Decline Versus Current eGFR and Subsequent ESRD Risk. , 2016, Journal of the American Society of Nephrology : JASN.

[10]  Sunjie Yan,et al.  Sarcopenia associated with renal function in the patients with type 2 diabetes. , 2016, Diabetes research and clinical practice.

[11]  T. Yoshimoto,et al.  Clinical relevance of dual-energy X-ray absorptiometry (DXA) as a simultaneous evaluation of fatty liver disease and atherosclerosis in patients with type 2 diabetes , 2016, Cardiovascular Diabetology.

[12]  W. Mitch,et al.  Mechanisms of muscle wasting in chronic kidney disease , 2014, Nature Reviews Nephrology.

[13]  J. Coresh,et al.  Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. , 2014, JAMA.

[14]  L. Peng,et al.  Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. , 2014, Journal of the American Medical Directors Association.

[15]  R. Kazancioglu.  Risk factors for chronic kidney disease: an update , 2013, Kidney international supplements.

[16]  T. Ikizler,et al.  Obesity in CKD--what should nephrologists know? , 2013, Journal of the American Society of Nephrology : JASN.

[17]  H. J. Yoo,et al.  Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: the Korean Sarcopenic Obesity Study , 2013, Clinical endocrinology.

[18]  D. Siscovick,et al.  Inflammation and coagulation markers and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA). , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[19]  C. Yen,et al.  Metabolic syndrome and insulin resistance as risk factors for development of chronic kidney disease and rapid decline in renal function in elderly. , 2012, The Journal of clinical endocrinology and metabolism.

[20]  Kohjiro Ueki,et al.  Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus , 2010, Journal of diabetes investigation.

[21]  K. Park,et al.  Sarcopenic Obesity: Prevalence and Association With Metabolic Syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA) , 2010, Diabetes Care.

[22]  F. Civeira,et al.  Usefulness of triglycerides-to-high-density lipoprotein cholesterol ratio for predicting the first coronary event in men. , 2009, The American journal of cardiology.

[23]  H. Yokoyama,et al.  Determinants of decline in glomerular filtration rate in nonproteinuric subjects with or without diabetes and hypertension. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[24]  Yasuhiko Tomino,et al.  Revised equations for estimated GFR from serum creatinine in Japan. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  J. Griffith,et al.  Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[26]  A. Murray,et al.  Kidney Function and Sarcopenia in the United States General Population: NHANES III , 2007, American Journal of Nephrology.

[27]  R. Baumgartner,et al.  Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. , 2004, Obesity research.

[28]  R. Leelawattana,et al.  Gender differences of regional abdominal fat distribution and their relationships with insulin sensitivity in healthy and glucose-intolerant Thais. , 2004, The Journal of clinical endocrinology and metabolism.

[29]  A. Levey,et al.  Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. , 1991, Journal of the American Society of Nephrology : JASN.

[30]  E. Oda.  New criteria for 'obesity disease' in Japan. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[31]  Eiji Oda,et al.  New criteria for 'obesity disease' in Japan. , 2002, Circulation journal : official journal of the Japanese Circulation Society.